UCLA Law Center on Repro Health, Law, & Policy
uclarepropolicy.bsky.social
UCLA Law Center on Repro Health, Law, & Policy
@uclarepropolicy.bsky.social
Reimagining the future of reproductive health, law, and policy in a time of urgent need.

The UCLA Law CRHLP is a think tank and research center developing long-term, lasting solutions that advance all aspects of reproductive justice.
Your gift today will go 2x as far to support:
Free legal services for those on the front lines, cutting-edge research, legal analysis, and policy solutions, defense of abortion pill access, youth health care rights, health data privacy, and more

Donate at: www.engage.ucla.edu/campaign/ucl...
October 22, 2025 at 6:21 PM
To learn more about the report and hear from advocates leading litigation to secure the protections guaranteed under these new amendments, join our upcoming webinar: Realizing the Promise of State Reproductive Freedom Amendments.

Pre-register at this link: forms.office.com/pages/respon...
September 22, 2025 at 9:07 PM
The new report provides a comparative overview of these amendments, including their specific guarantees, constitutional scope, and the standards of judicial review they create. The report details dozens of abortion restrictions in these ten states that pose conflicts with the new amendments.
September 22, 2025 at 9:07 PM
Join us for a webinar Sept. 30th discussing the impacts of state abortion policy on medical education, care provision, & decision-making among medical students and residents.

Register for the webinar: (forms.office.com/Pages/Respon...) and read the full report here law.ucla.edu/sites/defaul....
September 4, 2025 at 7:16 PM
The report examines how restrictive and protective state abortion policies influence where OB-GYN residents practice after residency. The report also provides research and policy recommendations to improve reproductive health care education, training, and state health policy.
September 4, 2025 at 7:16 PM
Through this letter organized by CRHLP and ANSIRH, hundreds of researchers remind the FDA that it’s actions must be based on the sound, rigorous, and transparent science that conclusively proves the safety and effectiveness of mifepristone generally and via telehealth.
August 27, 2025 at 3:41 PM